Vulcan Energy Resources Limited (VUL)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 0.730 |
|---|---|
| 52-week range | 0.711 – 3.834 |
| Return, 1 month / 3 months | −48.1% / −55.4% |
| Return, 1 year / 3 years | −80.4% / −47.1% |
| Trend | Below its 200-day average |
| RSI (14) | 17 |
| Volatility (1 year) | 58.2% |
| Worst drawdown (1 year) | -80.9% |
| Average daily value traded | 0.18M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vulcan Energy Resources is a resources company focused on producing lithium for the battery market from geothermal brine in the Upper Rhine Valley region of Germany. Its planned operations combine extraction of lithium from hot underground brines with generation of renewable geothermal heat and power. The company aims to supply battery-grade lithium chemicals to customers in the electric vehicle and energy storage industries, while its geothermal side is intended to provide low-carbon energy.
The shares are listed on the XETRA Stock Exchange in Germany under the code VUL, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vulcan Energy Resources Limited (VUL) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 0.730 on 19 October 2026.
Its price-based Market X-Ray is 13 out of 100 (a weak price profile), ranking 669 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 80.4% and over the last three months it fell 55.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 3 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -62.4% | ||
| From 52-week high | -80.7% | ||
| Momentum | 2 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -55.4% | ||
| 6-month return | -66.8% | ||
| 12-month return, skipping the last month | -62.2% | ||
| Stability (higher is calmer) | 10 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -80.9% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.18M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −14.6% |
|---|---|
| 1 month | −48.1% |
| 3 months | −55.4% |
| 6 months | −66.8% |
| 1 year | −80.4% |
| 3 years | −47.1% |
| 5 years | −92.0% |
Signals
| 50-day / 200-day average | 1.388 / 1.939 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.051 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.